PsycholgoicalTreatments Michaelis - Et - Al 2018 Epilepsia
PsycholgoicalTreatments Michaelis - Et - Al 2018 Epilepsia
DOI: 10.1111/epi.14444
1
Department of Neurology, Herdecke Community Hospital, University of Witten/Herdecke, Herdecke, Germany
2
Integrated Curriculum for Anthroposophical Medicine (ICURAM), Witten/Herdecke University, Herdecke, Germany
3
Department of Neurology, Center for Cognitive Neuroscience, Paracelsus Medical University, Salzburg, Austria
4
Division of Neurosurgery, Department of Surgery, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong Kong
5
Department of Clinical Psychology, Prince of Wales Hospital, Shatin, Hong Kong
6
Department of Psychology, Institute of Psychiatry, Psychology, and Neuroscience, King’s College London, London, UK
7
Academic Neurology Unit, Royal Hallamshire Hospital, University of Sheffield, Sheffield, UK
8
Departments of Psychiatry and Neurology, Rhode Island Hospital, Brown University, Providence, RI, USA
9
Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institute, Stockholm, Sweden
10
Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of
Medicine, Cincinnati, OH, USA
11
College of Nursing and Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA
Correspondence
Rosa Michaelis, Department of Neurology, Summary
Herdecke Community Hospital, University Given the significant impact that psychosocial factors and epilepsy treatments can
of Witten/Herdecke, Herdecke, Germany.
have on the health-related quality of life (HRQOL) of individuals with epilepsy
Email: [email protected]
and their families, there is great clinical interest in the role of psychological eval-
Funding information uation and treatments to improve HRQOL and comorbidities. Therefore, the Inter-
NIHR Maudsley Biomedical Research
national League Against Epilepsy (ILAE) charged the Psychology Task Force
Centre at the South London and Maudsley
NHS Foundation Trust and King’s College with the development of recommendations for clinical care based on evaluation of
London; Integrated Curriculum for the evidence from their recent Cochrane review of psychological treatments in
Anthroposophic Medicine; MAHLE
individuals with epilepsy. The literature search for a recent Cochrane review of
Foundation
randomized controlled trials investigating psychological treatments for individuals
with epilepsy constitutes the key source of evidence for this article. To provide
practical guidance to service providers, we provide ratings on study research
designs based on (1) the American Academy of Neurology’s Level of Evidence
system and (2) the Grading of Recommendations, Assessment, Development, and
Evaluation system. This paper is the culmination of an international collaboration
process involving pediatric and adult psychologists, neurologists, psychiatrists,
and neuropsychiatrists. The process and conclusions were reviewed and approved
by the ILAE Executive Committee. The strongest evidence for psychological
A.C.M. and J.L.W. contributed in equal measure to this article and should
be considered joint last authors of this contribution.
interventions was identified for the most common mental health problems, includ-
ing depression, neurocognitive disturbances, and medication adherence. Psycho-
logical interventions targeting the enhancement of HRQOL and adherence and a
decrease in comorbidity symptoms (anxiety, depression) should be incorporated
into comprehensive epilepsy care. There is a range of psychological strategies (ie,
cognitive behavioral therapy and mindfulness-based therapies) that show promise
for improving the lives of persons with epilepsy, and clinical recommendations
are provided to assist epilepsy health care providers in treating the comorbidities
and challenges associated with epilepsy and its treatments.
KEYWORDS
anxiety, depression, nonpharmacological seizure management, psychoeducation, screening, stigma
1 | INTRODUCTION
Key points
Among the treatment tools for individuals with epilepsy,
which include medication, diet, surgery, neuromodulation, • There are no previous specific recommendations
and psychological interventions, the latter most specifi- for clinical practice based on the quality of the
cally aim to improve health-related quality of life evidence for psychological treatments in patients
(HRQOL). Individuals with epilepsy have a lower with epilepsy
HRQOL than healthy individuals and individuals with • Ratings on study research designs were based on
other chronic diseases.1 Even a single seizure is associ- the American Academy of Neurology’s Level of
ated with reduced HRQOL.2 Several factors contribute to Evidence system
poor HRQOL, especially when seizure freedom cannot be • Evidence-based recommendations were based by
achieved, including medication side effects,3–5 the number the Grading of Recommendations, Assessment,
of antiepileptic drugs (AEDs),4,6 psychological symptoms Development, and Evaluation system
(eg, depression7,8), and psychosocial difficulties (eg, • The best evidence of effectiveness of psychologi-
unemployment).9 cal interventions was identified for depression,
Given the significant impact that psychosocial factors medication nonadherence, and neurocognitive
and epilepsy treatments can have on the HRQOL of indi- disturbances
viduals with epilepsy and their families, there is great clini- • Evidence supports that psychological therapies
cal interest in the role of psychological evaluation and should be considered in the treatment of individ-
treatments to improve HRQOL. Although several recent uals with epilepsy to improve HRQOL and
systematic and meta-analytic reviews of psychological comorbidities
treatments for individuals with epilepsy have been con-
ducted,10–13 and consensus statements regarding psycholog-
ical/psychiatric care for individuals with epilepsy have The findings are intended for health care practitioners
been published,14,15 specific recommendations for clinical around the world.
practice based on the quality of the evidence for psycho-
logical treatments have not yet been developed.
2 | METHOD OF EVALUATING THE
Therefore, the International League Against Epilepsy
QUALITY OF PSYCHOLOGICAL
(ILAE) charged the Psychology Task Force with the devel-
TREATMENTS
opment of recommendations for clinical care based on the
evaluation of the evidence from their recent Cochrane
2.1 | Operational definition of psychological
review of psychological treatments to improve HRQOL in
treatments
individuals with epilepsy.12,13 This paper is the culmination
of a process of international collaboration involving pedi- “Psychological treatment” refers to a broad range of inter-
atric and adult psychologists, neurologists, psychiatrists, ventions for children and adults that encompass psycholog-
and neuropsychiatrists. The process and conclusions were ical or psychiatric nonpharmacological interventions for
reviewed and approved by the ILAE Executive Committee. individuals, families, and groups, as well as self-/family
1284
| MICHAELIS ET AL.
management, adherence, and educational interventions (see Tolin et al19 to include 3 levels (VERY STRONG,
Table 1). Intervention elements may be administered on STRONG, and WEAK recommendation) for evaluation of
their own or in combination. Whereas some intervention the quality of evidence for RCTs in the clinical psychology
elements are universally applicable, other elements address literature. Using Tolin’s 3 levels (see Table 2), we evaluate
epilepsy and seizures more specifically. Interventions can the quality of evidence for psychological treatments for
target specific mental health disorders (anxiety, depression) specific disorders (eg, depression, anxiety) in addition to
or particular behaviors related to the management of epi-
lepsy (adherence, coping). Although differences in theoreti-
cal underpinnings and treatment targets limit the scope of
comparisons,11 there is overlap among the psychological
treatments that can be applied to individuals with epilepsy.
seizure outcomes, adherence, and epilepsy education and Cultural issues and differences that may affect implementa-
provide clinical recommendations for use of indicated treat- tion and utilization will be mentioned; however, an elaborate
ments. If the evidence base for a given treatment is of low discussion of cultural considerations and implications is
quality or lacking entirely, we highlight the need for further beyond the scope of this paper.
research in this area. We also provide a brief overview of The authors are aware of the challenges of clinical trans-
treatment delivery, including options for resource-poor set- lation marked by the gap between ideal care and real care
tings, as well as service considerations including recom- constraints in busy clinical settings, in which trained staff
mendations for inpatient and outpatient treatment facilities often necessary to deliver evidence-based interventions are
and for training. lacking. However, it is relevant for all providers to focus on
early identification and prevention of comorbidity, which
could be time- and cost-effective, as HRQOL is a significant
2.4 | Notable considerations predictor of health care charges in epilepsy, with poorer
Psychological treatments tend to be complex multicompo- HRQOL predicting greater health care charges.21–23
nent interventions, that is, several intervention components
may be incorporated in diverse therapeutic approaches (eg,
3 | AVAILABLE EVIDENCE FOR
education plus skills training) and studies with different treat-
PSYCHOLOGICAL TREATMENT ACROSS
ment targets, and therefore the same intervention components
THE EPILEPSY SPECTRUM: RELEVANCE
will be mentioned in various sections throughout this article.
TO CLINICAL PRACTICE AND
Special issues relating to pediatric populations will be
RECOMMENDATIONS
included in each subsection. Level 3 and Level 4 Specialized
Epilepsy Centers are required to have a psychologist and
3.1 | Evidence-based screening: Selecting
social worker as part of their centers; however, which psy-
patients for psychological treatment in the
chosocial services are offered are not specified.20 Because
clinical setting
psychological treatment delivery varies within and across
countries and settings, we will mostly refer to “mental health
3.1.1 | Evaluation of the evidence for
care providers” without specifying their professional groups.
psychological screening
Mental health care providers can include psychiatrists, psy-
chologists, psychotherapists, licensed clinical social workers, Psychological disorders are at least twice as common in
neurologists with therapy training, neuropsychiatrists, and individuals with epilepsy as the general population24,25;
psychiatric nurses, among other mental health professionals. therefore, standard screening procedures for patients newly
1286
| MICHAELIS ET AL.
diagnosed with epilepsy, as well as for patients with as executive functioning and oppositional or hyperactive
chronic epilepsy, should be integrated into routine epilepsy behaviors.44 Caregivers are also critical reporters when
care.15,21,26 Symptom screening assists in the identification children have cognitive impairment developmental delays
of individuals who may benefit from psychological treat- or are too young to provide valid responses.
ments. To address the issue, the AAN has included screen-
ing for psychiatric or behavioral disorders at each epilepsy
3.1.3 | Recommendations for psychological
encounter as a new quality measure for the delivery of
screening
optimal care and better outcomes for individuals with
epilepsy.27 Psychological screening is indicated, given the high preva-
Epilepsy-specific measures are now available to evaluate lence of mental health disorders in individuals with epi-
psychosocial functioning, including depressive symptoms lepsy. According to the AAN practice guideline, patients
and HRQOL. For example, the 6-item self-report survey, with epilepsy should complete mental health screenings as
Neurological Disorders Depression Inventory for Epilepsy part of routine epilepsy care.27 Specific clinical recommen-
(NDDI-E), is an epilepsy-specific screening tool for major dations include:
depression,28 and its feasibility has been demonstrated in a
routine clinical setting.29 Annual use of the NDDI-E has 1. Each epilepsy visit should include, at a minimum, a
previously been recommended by the ILAE neuropsychi- clinical question regarding mental health and quality of
atric commission.26 It has been validated in many lan- life. Screening is encouraged at epilepsy diagnosis, prior
guages, is freely available, and has been tailored for use in to and following AED initiation or changes, and at rou-
young people (NDDI-E-Y).30 tine time intervals (eg, yearly).
Screening measures for other aspects of psychological 2. Practitioners should consider multi-informant screenings
functioning (eg, HRQOL, AED side effects) may provide for children and also for adults, when indicated and
beneficial information regarding patient well-being. Psycho- available.
metrically sound and free epilepsy-specific HRQOL tools 3. A measure of psychological functioning should be
include the Quality of Life in Epilepsy (QOLIE) adult administered prior to AED initiation and over the course
(QOLIE-10, QOLIE-31, QOLIE-89) and adolescent (QOLIE- of AED treatment.
48) measures31,32 and the newer PedsQL Epilepsy Mod- 4. Practitioners should consider including a standardized
ules.33,34 Parent-proxy report of their child’s HRQOL can evaluation of AED side effects.
also be obtained via the Quality of Life in Childhood Epilepsy 5. Practitioners are encouraged to consider a measure of
Questionnaire (4-18 years old).35,36 Additionally, the assess- HRQOL.
ment of psychiatric/psychological symptoms at baseline can 6. If screening identifies significant symptoms or a prob-
inform the choice of an AED, given that a history of psycho- lem, patients should undergo a formal mental health
logical symptoms increases the vulnerability to subsequent assessment to inform the selection of the appropriate
behavioral/emotional side effects.37,38 Subsequently, this treatment elements based on individual needs. Family
baseline information can help determine whether psychologi- members may provide key details of past events during
cal symptoms arising during the course of treatment could be this evaluation.
an AED side effect or an exacerbation of a premorbid or
comorbid psychological disorder. Continued assessment of
3.2 | Psychoeducation for patients, parents,
AED side effects over the course of epilepsy can inform
and caregivers
changes to medications and/or alternative treatments (eg, diet)
and is important to consider at each epilepsy visit given the Psychoeducational interventions involve the dissemination
relationship between side effects, adherence, and HRQOL.39 of knowledge and education regarding seizures, treatments,
Standardized evaluation of side effects is available through comorbid conditions, and lifestyle challenges. Most psy-
use of the Pediatric Epilepsy Side Effects Questionnaire40 and chological interventions involve an aspect of education; this
the Liverpool Adverse Event Profile.41,42 next section is reserved solely for interventions that focus
primarily on education and not on the development of
behavioral, cognitive, or meditation skills.
3.1.2 | Considerations for pediatric
populations
3.2.1 | Evaluation of the evidence for
Multi-informant screening is ideal for pediatric populations.
psychoeducational interventions
Although children are often better reporters of their own
internalizing symptoms,43 caregivers can provide a unique According to several national guidelines (eg, Scottish Inter-
and beneficial perspective for some behaviors/deficits, such collegiate Guidelines Network; National Institute of
MICHAELIS ET AL. | 1287
Clinical Health and Care Excellence, United Kingdom; friendly terms, with pictorial representations when possible
American Epilepsy Society), additional personalized infor- or game-based formats. Depending on the child’s develop-
mation on treatment, possible outcomes, and specific risks mental level and chronological age, clinicians may wish to
must be provided to patients and families following an epi- discuss some aspects of epilepsy with caregivers only (eg,
lepsy diagnosis. Patients may experience challenges with sudden unexpected death in epilepsy).
adjustment to and worries about the epilepsy diagnosis
after learning about potential legal, psychosocial, and
3.2.4 | Specific clinical recommendations for
health ramifications.45 Additionally, research indicates that
epilepsy psychoeducation
individuals with epilepsy and/or their caregivers frequently
misunderstand basic information about epilepsy, including Specific clinical recommendations for epilepsy psychoedu-
knowledge about their diagnosis, seizure precipitants or cation include:
triggers, purpose and potential side effects of AEDs, safety
concerns, and the risks of seizures.46–50 A large amount of 1. Each patient with epilepsy should receive psychoeduca-
the variance in HRQOL is explained by individuals’ per- tion.
ceptions of their illness,51,52 and educational interventions 2. Because a diagnosis of epilepsy may create fear and
may modify illness perceptions and improve an individual’s shock in individuals and/or families, a follow-up to the
HRQOL. Therefore, it is prudent to follow up the initial initial diagnosis is recommended to provide specific
communication of an epilepsy diagnosis with (psycho)edu- details regarding psychoeducation for a particular
cation about seizures, treatments and their side effects, patient’s epilepsy symptoms, characteristics, and needs.
comorbid conditions, and self-management and quality of 3. Psychoeducation may focus on seizure knowledge and
life issues.26 The AAN recommends providing personalized treatments, information needs and support, and/or
epilepsy safety information and education on a yearly comorbid conditions.
basis.27 4. Psychoeducation may be provided individually or in a
Of the 15 RCTs investigating educational interventions, group setting.
4 studies were LOE II,53–56 4 studies57–60 were LOE III, 5. Psychoeducation should be provided to patients with
and 7 studies61–67 were LOE IV. All 4 LOE II studies consideration for their developmental level, health liter-
reported improvements in their various primary outcomes: acy, and information and support needs.
medication adherence,53 epilepsy knowledge and satisfac- 6. Clinicians are encouraged to select an evidence-based
tion with information and support,54 medication-related educational intervention that suits the needs of their
problems,54 and HRQOL.56 The LOE II studies investi- patients (adult vs child, group vs individual) and to
gated psychoeducational interventions that were delivered assess before and after outcomes (eg, knowledge) to
by specialized epilepsy nurses or trained medical doctors to monitor whether their patients are learning from the
individuals and included personalized information during intervention.
routine visits or a general information package during a 7. Clinicians are encouraged to continue to routinely assess
series of scheduled sessions. their patient’s needs for psychoeducation about epilepsy,
its treatments, and comorbid conditions across the
lifespan.
3.2.2 | Psychoeducational interventions for
epilepsy receive a GRADE recommendation of
STRONG 3.3 | Depressive symptoms
There is moderate- to high-quality evidence that psychoed- There is substantial evidence supporting the idea of a bidi-
ucational interventions produce a clinically meaningful rectional relationship between epilepsy and depression.
improvement in health-related outcomes in individuals with Shared neurobiological mechanisms, for example, lesion of
epilepsy, including medication adherence, satisfaction with mesial temporal structures and hippocampus volume loss,68
information and support, and HRQOL (Table 3). shed light on the reasons for their coexistence and inter-
linking relationship. Depression may predate the onset of
epilepsy; a history of depression is associated with a two-
3.2.3 | Considerations for pediatric
to fourfold increase in the risk for an unprovoked
populations
seizure.69–71 Depression can also be a psychological reac-
Clinicians are encouraged to take into consideration the tion to epilepsy, and it is a significant predictor of seizure
developmental abilities of children and level of understand- outcomes with pharmacological and surgical treat-
ing when discussing an epilepsy diagnosis with children ments.72,73 There is newer evidence for specific clusters of
and their families. Material should be presented in child- depressive symptoms in persons with epilepsy, with the
1288
|
more common cluster consisting of a cognitive phenotype Notably, similar to adults, negative cognitions (ineffective-
(eg, self-critical cognitions, such as ineffectiveness).74 ness) may be more relevant than mood symptoms in youth
with epilepsy, and interventions should target such symp-
toms.91 Those who have risk factors for depression (eg,
3.3.1 | Evaluation of the evidence for
family history of mood disorders, coexisting medical condi-
interventions for depressive symptoms
tion, psychosocial adversities) should be evaluated by clini-
Nine RCTs investigated psychological interventions for indi- cians at regular intervals92 for the prevention of clinical
viduals with epilepsy with depression symptoms75–83 or as a depression, early diagnosis, and treatment.
preventative intervention for clinical depression in patients
with subthreshold depressive symptoms.84 The following 7
3.3.4 | Specific clinical recommendations for
studies measured depressive symptoms as secondary out-
depressive symptoms
come: 4 RCTs investigated psychological interventions,85–88
1 RCT investigated a self-management program,89 and 2 Specific clinical recommendations for depressive symptoms
RCTs investigated educational programs.55,65 include:
Of these 16 studies, 1 study was LOE I,84 5 studies were
LOE II,55,75,76,79,86,89 2 studies were LOE III,78,85 and the 1. Depression should be assessed in routine epilepsy care
remaining 8 studies were LOE IV.53,65,77,81–83,87,88 Most following epilepsy diagnosis regardless of drug respon-
LOE I and II studies reported significant reduction in depres- siveness.
sive symptoms; exceptions were 1 depression-specific inter- 2. Psychological interventions can be provided individually
vention LOE II study that reported a reduction in suicidal or in a group format.
ideation but no other significant changes on a generic depres- 3. Treatment components may include behavioral interven-
sion scale75,76 and the educational program55 that did not find tion (eg, social activation) and skill-based interventions
any significant changes in depressive symptoms. The highest (eg, problem solving, social skills training).
level of evidence pertains to skill-based training and behav- 4. Treatment outcomes should be monitored using stan-
ioral interventions. Techniques comprised behavioral and dardized inventories/rating scales.
social activation, problem solving and goal setting skills,
training of social competencies, and identifying social sup-
3.4 | Treatment nonadherence and
port. These were particularly effective in addressing behav-
self-management
ioral symptoms of depression and its associated limitations,
such as social withdrawal, hypersomnia, physical inactivity, Adherence is defined as the extent to which a person’s
and unemployment (Table 4).75,76,84 behavior coincides with medical or health advice.93 In con-
trast, self-management is defined as the interaction of
health behaviors and related processes that patients and
3.3.2 | Interventions for depressive symptoms
families engage in to care for a chronic condition.94 AED
in epilepsy receive a GRADE recommendation
nonadherence ranges from 25% to 50%95,96 in adults and
of STRONG
43%-58%39,97 in children with epilepsy. The consequences
There is moderate- to high-quality evidence that skill-based of nonadherence can be severe, including continued sei-
and behavioral psychological interventions produce a clini- zures,39,98 poor HRQOL,99 higher health care costs and uti-
cally meaningful effect on depressive symptoms, including lization,100 pharmacoresistance,101 and even death.102
suicidal ideation in individuals with epilepsy.
3.4.1 | Evaluation of the evidence for
3.3.3 | Considerations for pediatric interventions for adherence and self-
populations management
There are limited data for the treatment of depression or Three RCTs investigated psychological interventions specifi-
depressive symptoms in pediatric epilepsy populations84; cally aiming at increasing medication adherence.103–105
thus, clinicians are encouraged to base treatment on the Two studies investigated self-management interventions
results of treatment trials conducted with children with that measured medication adherence as a secondary out-
depression in nonepilepsy populations.90 Treatment may come.106,107 Two studies104,107 were LOE II, and the 3
include psychoeducation to children and family as well as remaining studies were LOE IV.103,105,106 Significant
cognitive-behavioral therapy for children,90 and most child- results were reported for the LOE II pediatric adherence
focused depression protocols include strong family involve- intervention, whereas no significant changes were reported
ment in treatment (eg, encouragement of mastery of skills). for the self-management program. Thus, the highest level
1290
|
↑, significant increase/high risk of bias; ↓, significant decrease/low risk of bias; ↔, result was not significant/unclear risk of bias; AAN, American Academy of Neurology; BAI, Beck Anxiety Inventory; BDI, Beck Depres-
sion Inventory; CBT, cognitive behavioral therapy; CES-D, Center for Epidemiological Study on Depression Scale; DACL, Depression Adjustment Checklist; GHQ, General Health Questionnaire; HADS-A, Hospital Anxi-
ety Depression Scale–Anxiety; HADS-D, Hospital Anxiety Depression Scale–Depression; HAMD, Hamilton Depression Scale; HSCL-20, Hopkins Symptom Checklist-2; LOE, Level of Evidence; MINI, Mini International
Neuropsychiatric Interview; MMPI, Minnesota Multiphasic Personality Inventory; MT, mindfulness therapy; NDDI-E, Neurological Depressive Disorders Inventory–Epilepsy; PHQ-9, Patient Health Questionnaire-9; SFT,
systemic family therapy.
MICHAELIS
ET AL.
MICHAELIS ET AL. | 1291
(Continues)
AAN LOE
children with epilepsy about problem solving strategies.
class
IV
IV
II
II
3.4.2 | Adherence/self-management
interventions for epilepsy receive a GRADE
Attrition
recommendation of STRONG
There is moderate- to high-quality evidence that multicom-
↓
↑
↓
ponent interventions that include education and problem
assessment
solving produce a clinically meaningful effect on medica-
Masked
tion adherence in children with epilepsy (Table 5).
↓
↓
?
3.4.3 | Considerations for pediatric
populations
Concealed
allocation
Parents are encouraged to partner with children and adoles-
cents to manage the treatment regimen, including supervi-
↓
↓
?
sion regarding taking AEDs and avoidance of seizure
triggers. Parental involvement can aid in ensuring that
Randomization
tbcrrgut=1][?-}
tbcbgsgut=1][?
tpct=-0.5pt][?
tbcfmtv=b][?
tbcbgc=%20
adherence does not decline in adolescents, a vulnerable
ColourA][?
(ancestor::
thead))"[?
developmental period. Technology-focused adherence solu-
skip]>↓
tions may be particularly salient for adolescents.108
↓
3.4.4 | Specific clinical recommendations for
Blinding
T A B L E 5 AAN LOE of studies investigating interventions aiming at improving medication adherence
adherence/self-management ↑
↑
↑
?
Specific clinical recommendations for adherence/self-man-
agement include:
AGAS ↔, MEMS ↔
Primary outcomes
MAS ↑
ence and problem-solve ways to improve adherence.
3. Technology-focused solutions should be used that
enhance reminders and that may be well received and
beneficial in establishing good adherence behaviors.
problem solving
Family-tailored
intervention
Treatment
3.5 | Seizures
method
MI
Dilorio 2011106
3.5.1 | Evaluation of the evidence for 1. Clinicians are encouraged to inquire about their
interventions for seizure-related outcomes patients’ interest in learning mindfulness training on
awareness and nonjudgmental acceptance of seizure-
Four RCTs investigated psychological interventions aiming
related physical symptoms.
primarily to decrease seizure frequency.88,113–116 Five stud-
2. Clinicians should provide education to patients and fam-
ies investigated psychological interventions,75,76,82,86,109,110
ily members on the interlinking relationship between
and 2 studies58,59 investigated an educational program that
psychological factors and seizures, and therefore psy-
targeted nonseizure outcomes and included seizure fre-
chological treatments could be included as part of epi-
quency as a secondary outcome. Two studies75,76,86 were
lepsy care.
LOE II, 3 studies were LOE III,58,59,113 and the remaining
3. Clinicians are encouraged to investigate details of sei-
6 studies were LOE IV.82,88,109,110,114–116 A significant
zure development (eg, seizure precipitants, coping) and
decrease in seizure frequency was reported in 1 LOE II
to make lifestyle recommendations relevant to individ-
study86 that focused on mindfulness training together with
ual patients.
a set of lifestyle recommendations that facilitated coping
4. Mindfulness training designed for patients with epilepsy
with seizure-related disturbances and stressful situations,
should be an adjunctive treatment option where
and in 1 of the 2 educational programs58 that were both
resources allow.
rated LOE III. Therefore, the highest level of evidence per-
tains to mindfulness-based therapies as well as lifestyle rec-
ommendations that facilitated stress coping. These allow 3.6 | Anxiety
patients to notice and acknowledge their emotional pro-
Panic and generalized anxiety are more frequent in adults
cesses and physical symptoms related to their seizures, so
and older adolescents with epilepsy than in the correspond-
as to facilitate acceptance and coping.
ing general population and may have a marked negative
impact on HRQOL.117 In the assessment of anxiety disor-
3.5.2 | Psychological interventions for ders, clinicians need to consider the temporal relationship
seizure-related outcomes receive a GRADE of anxiety symptoms and seizures. This subsection focuses
recommendation of WEAK on interictal anxiety symptoms that may be related to a fear
of future seizures as well as fears of epilepsy-related conse-
The evidence is inconclusive, suggesting an important area
quences (psychosocial worries) and complications (such as
for future research. Whereas there is moderate- to high-
injury, brain damage, memory impairment). The anticipa-
quality evidence that mindfulness-based therapies and
tory anxiety about seizures may also take the form of sei-
lifestyle modifications that focus on improving HRQOL
zure phobia, which may lead to maladaptive avoidance and
produce a clinically meaningful effect on seizure frequency
isolation. It is, however, important to note that equally dis-
in individuals with epilepsy, there is also evidence that
abling anxiety symptoms (eg, social phobia, generalized
cognitive behavioral therapy–based interventions focused
anxiety) may also occur separately from seizure-related
on improving depressive symptoms do not have a clinically
worries and are also important to address.118 Perceived
meaningful effect on seizure-related outcomes in individu-
stigma is a risk factor for increased anxiety, which again
als with epilepsy (Table 6).
illustrates the interrelatedness of psychological issues.119,120
implementation of mindfulness exercises that may facilitate those with temporal lobe epilepsy and drug-resistant epi-
the process of awareness, experience, and finally accep- lepsy.122,123 The details of cognitive assessment and train-
tance of feelings of anxiety. ing in epilepsy were thoroughly discussed in separate
recommendation statements.124 Instead of providing reha-
bilitation or training that targets objective cognitive deficits,
3.6.2 | Interventions for anxiety symptoms in
psychological treatments may aim at managing the interre-
epilepsy receive a GRADE recommendation of
lationship between mood, anxiety, and subjective cognitive
WEAK
complaints, which may not be reflected in objective evi-
The evidence is somewhat inconclusive, suggesting this is dence of cognitive impairment.125
an important area for future research. Although there is
moderate- to high-quality evidence that mindfulness-based
3.7.1 | Evaluation of the evidence for
interventions produce a clinically meaningful effect on anx-
interventions for neurocognitive disturbances
iety symptoms in individuals with epilepsy, several other
moderate- to high-quality studies did not demonstrate a Only 1 RCT investigated a psychological intervention
meaningful effect. Notably, in many of these interventions, specifically focused on cognitive symptoms (LOE III),85
anxiety was a secondary outcome (Table 4). and 1 other study86 measured cognitive functions as sec-
ondary outcome (LOE II). The highest level of evidence
pertains to a mindfulness-based training for individuals
3.6.3 | Considerations for pediatric populations with epilepsy, aiming to cultivate patients’ self-awareness
Many parents refer to the experience of their child’s first and focused attention. The completion of this treatment
seizure as traumatic, which may lead to anxieties concern- was associated with significant improvements in objective
ing the condition.57 As a consequence, children may measures of delayed verbal memory in patients with drug-
develop a fear of seizures by observing anxious parental resistant epilepsy compared to controls86; however, no
reactions.121 Psychological interventions that aim at allevi- changes were reported in other cognitive measures, includ-
ating anxiety in children may also have a secondary goal ing attention, nonverbal memory, and executive functions.
of addressing parents’ fear of seizures.114,115 Similar to A home-based self-management program (HOBSCOTCH)
depression, caregiver involvement in encouragement of incorporating psychoeducation, self-awareness training,
skill rehearsal is important for skill mastery in children. compensatory strategies, and cognitive training has been
developed and has been shown to be associated with sig-
nificant improvement in objective cognitive performance.85
3.6.4 | Specific clinical recommendations for
Using acceptance and commitment therapy tailored for
anxiety symptoms
individuals with epilepsy, Lundgren et al109,110 guided indi-
Specific clinical recommendations for anxiety symptoms viduals to develop a nonjudgmental acceptance of their
include: memory functions and refocused patients on the achieve-
ment of valued life goals despite the preconceived obstacle
1. Clinicians are encouraged to assess interictal anxiety of impaired cognitive functioning. In a controlled study
symptoms that may be related to a fear of future sei- (LOE IV), this intervention was found to be associated
zures and fear of epilepsy-related complications. with significantly improved HRQOL.109,110
2. Complex psychosocial worries, such as perceived
stigma, may exacerbate symptoms of anxiety, and
3.7.2 | Interventions for neurocognitive
should be evaluated and addressed.
disturbances in epilepsy receive a GRADE
3. The highest level of evidence pertains to the implemen-
recommendation of STRONG
tation of mindfulness exercises that may facilitate the
process of awareness, experience, and finally acceptance There is moderate- to high-quality evidence that mindful-
of feelings of anxiety. Therefore, health care providers ness-based interventions produce a clinically meaningful
are encouraged to refer patients with anxiety symptoms effect on neurocognitive disturbances in individuals with
for mindfulness-based interventions to alleviate their epilepsy.
anxiety symptoms.
3.7.3 | Considerations for pediatric
3.7 | Neurocognitive disturbances populations
Cognitive impairment can be associated with epilepsy and The prevalence of attention-deficit/hyperactivity disorder
adds to disability beyond seizures alone, particularly in (ADHD) is higher in pediatric epilepsy than in the general
MICHAELIS ET AL. | 1295
population, with rates of 30%-40% in children with epi- epilepsy are less likely to be well educated, to be
lepsy.126 There are very few studies examining the benefit of employed, and/or to have a romantic partner.133 They also
psychological interventions for children with epilepsy and experience social difficulties, including social isolation,
comorbid ADHD,127 and our search did not yield RCTs of social competence, and other social skills deficits.134 Fam-
psychotherapy for epilepsy and ADHD. Expert reviews on ily functioning, including communication, social support,
treatment of ADHD in individuals with epilepsy emphasize adaptation, mastery, and conflict, is often impacted by epi-
the need to address cognition.128 Moreover, the general child lepsy.135 Personal experiences with epilepsy may involve
literature has a strong evidence base for the efficacy of behav- perceived stigma, defined as a set of negative and often
ioral interventions in reducing ADHD symptoms in chil- unfair beliefs about something.136 Perceptions of stigma
dren.129 Given the comorbid learning disabilities and the can lead to concealment to avoid the anticipated negative
neurocognitive deficits common in children with epilepsy, it consequences of epilepsy disclosure in societies at all
is also important to discuss potential learning problems, pro- stages of economic development.120,137 Although the
vide access to resources (eg, educational interventions), com- strength of the perception of stigma may be associated with
municate with school personnel, and facilitate referrals for internal factors, such as low self-esteem,132 there are also
neuropsychological evaluations. Commercially available external factors, including cultural and religious differences
products have also recently been tested in epilepsy and may contributing to stigma.138 The extent to which indepen-
prove to be beneficial.130 A new Web-based executive func- dence and autonomy are encouraged also varies consider-
tioning intervention for adolescents is currently being tested ably between cultures. Regardless of these cultural
and may be one way to help youth with epilepsy overcome differences, epilepsy may result in significant restrictions in
cognitive skill deficits.131 an individual’s social functioning and independence, which
may be self-imposed or imposed by others.61
3.7.4 | Specific clinical recommendations for
neurocognitive disturbances 3.8.1 | Evaluation of the evidence for
interventions for social and family problems
Specific clinical recommendations for neurocognitive dis-
and stigma
turbances include:
Regardless of their primary outcome measure, most psycho-
1. Clinicians are encouraged to be aware of the interrela- logical treatments employ strategies to actively strengthen
tionship between mood, anxiety, and subjective cogni- the social network and build social support, to limit overpro-
tive complaints, which may not be reflected in objective tection or inappropriate dependence and enhance self-
evidence of cognitive impairment. responsibility, to improve communication, to encourage
2. Cognitive assessment and training may complement acceptance of the diagnosis, and to help patients deal with
mindfulness-based training aiming to increase patients’ emotional difficulties. Specific to the social domain, 1 LOE
self-awareness and focused attention. I psychological intervention study emphasized social
3. Several strategies can be built into psychological inter- skills,84 1 LOE II psychological intervention study focused
ventions for individuals with epilepsy with subjective on social activation,75,76 and 1 LOE II self-management
neurocognitive disturbances to enhance a sense of self- intervention focused on community integration and optimiz-
reliance. These techniques include incorporating written ing epilepsy-related communication.89 A LOE II interven-
handouts, joint reviews of the preceding sessions to tion incorporated family components into adherence and
reinforce memory for session content, shortening treat- utilized an outcome measure that included an aspect of fam-
ment sessions, and audio-recording sessions to enable ily functioning, parenting (child support, autonomy, disci-
the individuals to review the content between sessions. pline).104 LOE III and IV psychological interventions
Such techniques have been found to be beneficial.77 included assertion training,81 communication skills,77 identi-
4. In the absence of data to support the efficacy of behav- fication of social support,80 anger management,87 and moti-
ioral interventions tailored to children with epilepsy and vational interviewing.139 LOE II educational programs
ADHD, clinicians are encouraged to apply the evi- included information about social, family, and occupational
dence-based behavioral techniques supported in the gen- issues,53,55 and LOE III educational programs included con-
eral child literature. tent/skills for communication, self-responsibility, and self-
management,57 self-advocacy topics,62 coping,59,60 and
psychosocial and occupational issues.58 One LOE IV educa-
3.8 | Social and family problems and stigma tional program in Nigeria65 addressed specific cultural mis-
Having epilepsy may be associated with vocational, educa- conceptions about seizures and their treatment. Of note,
tional, social, and personal difficulties.132 Individuals with most of the interventions addressing family components are
1296
| MICHAELIS ET AL.
participants’ practice of relevant skills by embedding community/public health care professionals) and barriers
knowledge into treatment sessions spread out over time. (eg, poor public transportation).
Education protocols can, for example, either be delivered en 4. A group setting may be more cost-effective than indi-
bloc as a 2-day course or in a weekly format. Half of all vidual sessions and offer unique advantages (eg,
14 studies investigating educational programs53–55,61–63,66 exchange of individual experiences, elicitation of group
had chosen to deliver their interventions using at least 2 support and encouragement).
sessions that were at least 1 month apart. LOE I and II 5. Although it is beyond the scope of this paper to discuss
studies of psychological interventions and 1 self-manage- the differences in treatment implementation and delivery
ment intervention89 reporting significant primary outcome across cultures, we encourage the implementation of
results were implemented in at least 4 sessions86 that were basic elements of psychological interventions, including
delivered with a maximum frequency of weekly sessions84 education and self-help resources (including, eg, relax-
and a minimum frequency of 2-3 weeks between ses- ation CDs, seizure tracking devices).
sions.75,76 Depending on their primary treatment method, 6. Although providers and patients may wish to compress
these interventions included practice assignments between intervention content, they are encouraged to consider
sessions. Booster sessions following a more intense treat- the dose(s) of treatments suggested by the empirical lit-
ment period may increase skill retention.109,110 erature to permit sufficient scope for consolidating
change by including practice by participants between
sessions.
4.2 | Home-based, group-based, and
7. To decrease anxieties in nonmedical mental health care
telehealth intervention delivery in epilepsy
professionals over treating patients with seizures, a pro-
receive a GRADE recommendation of
tocol should be generated for individual patients, detail-
STRONG
ing how seizures that may occur during treatment
There is moderate- to high-quality evidence that home- sessions should be managed.
based, group-based, and telehealth-based treatments pro-
duce a clinically meaningful effect on a broad range of
symptoms in individuals with epilepsy, including suicidal 5 | TRAINING RECOMMENDATIONS
ideation and depressive symptoms, as well as HRQOL.
Mental health providers who have had extensive profes-
sional training in the delivery of psychological interven-
4.3 | Considerations for pediatric populations tions may have greater capacity to deliver psychological
Electronic and telehealth treatment modalities (eg, tele- treatment for people with epilepsy than epilepsy-specific
phone, computer, mobile health, electronic health) may be providers who have had very limited (if any) training in
particularly beneficial to families of children with epilepsy, providing noneducational psychological interventions. Med-
who must consider balancing the needs of the child with ical professionals such as epilepsy nurses are equipped to
epilepsy and other children, difficulty taking time off from provide educational and basic self-management interven-
work/school, et cetera to engage in psychological treatment. tions and can be equipped for other psychological interven-
Adolescents have a strong preference for technology and tions (cognitive behavioral, mindfulness) with specific
are thus also more likely to be amenable to telehealth treat- training (eg, psychiatric nursing degree, completed training
ment modalities.147 on a specific treatment protocol). Thus, we would recom-
mend the following:
4.4 | Specific clinical recommendations for
1. It is important to acknowledge that the required training
treatment delivery and implementation
for specific interventions depends on the professional
Specific clinical recommendations for treatment delivery background and expertise of the person delivering the
and implementation include: intervention, the nature of the treatment package, and
how well the treatment has been described and manual-
1. The described treatment elements may be delivered ized.
face-to-face in clinical settings or home-based, via tele- 2. A mental health professional delivering the intervention
health technology. elements should have basic knowledge regarding epi-
2. Psychological interventions can be provided individually lepsy, including etiology and classification of seizures,
or in a group format. treatment options, and psychopathology.26
3. Clinicians are encouraged to choose treatment delivery 3. Conversely, a medical professional delivering any psy-
modalities based on local treatment resources (eg, chological intervention elements should receive training
1298
| MICHAELIS ET AL.
in the administration of psychological interventions in publication by the ILAE. Opinions expressed by the
general as well as specific, detailed training in the authors, however, do not necessarily represent the policy or
implementation of the specific intervention protocol position of the ILAE. We thank Graham Chan from the
being administered. editorial team at Cochrane Epilepsy for supporting us with
4. Epilepsy-specific psychological interventions should the literature search and all related questions.
ideally be implemented by professionals in direct con-
tact with the diagnostician and the treating medical epi-
lepsy specialist. DISCLOSURE OF CONFLICT OF INTEREST
5. Some interventions, such as PEARLS, UPLIFT, and
MOSES/FAMOSES, offer and require the completion None of the authors has any conflict of interest to disclose,
of program-specific training prior to implementation, with the exception of L.H.G. This work represents indepen-
with variability in the extent and mode of dent research partially funded (R.M.) by the MAHLE
training58–60,75,76,80,83,148–150 to ensure the treatment is Foundation and the Integrated Curriculum for Anthropo-
delivered as intended. sophic Medicine. This work also represents independent
research partially funded (L.H.G.) by the National Institute
for Health Research (NIHR) Maudsley Biomedical
Research Centre at the South London and Maudsley
6 | CONCLUSION
National Health Service (NHS) Foundation Trust and
All patients should be screened for mental health comorbidi- King’s College London. The views and opinions expressed
ties, and patients with psychological symptoms should be are those of the author and not necessarily those of the
referred for further evaluation and treatment of indicated or NHS, the NIHR, or the Department of Health. We confirm
at-risk psychological symptoms. Evidence supports that psy- that we have read the Journal’s position on issues involved
chological therapies that target comorbid mental health in ethical publication and affirm that this report is consis-
symptoms and HRQOL should be considered in the compre- tent with those guidelines.
hensive treatment of individuals with epilepsy. The strongest
evidence was identified for the most common mental health
problems, including depression, as well as health behaviors, ORCID
such as adherence. Treatments for these disorders and chal-
Rosa Michaelis https://orcid.org/0000-0002-2577-0824
lenges received STRONG recommendations. Treatment pro-
Laura H. Goldstein http://orcid.org/0000-0001-9387-
tocols and training on the intervention techniques and
3035
delivery are available for many of the interventions dis-
Markus Reuber http://orcid.org/0000-0002-4104-6705
cussed. Few treatments have been evaluated with the same
William Curt LaFrance Jr. http://orcid.org/0000-0002-
rigor in children and adolescents compared to adults, and
4901-3852
we lack studies focusing on anxiety as an intervention target
and primary outcome. In addition, RCTs investigating psy-
chological interventions in other common comorbidities, REFERENCES
such as ADHD and substance abuse in adults and children
with epilepsy, are absent. However, there is a strong evi- 1. Wang J, Wang Y, Wang LB, et al. A comparison of quality of
dence base for the benefit of psychological interventions in life in adolescents with epilepsy or asthma using the Short-Form
treating these disorders in the general population, which can Health Survey (SF-36). Epilepsy Res. 2012;101:157–65.
2. Modi AC, Ingerski LM, Rausch JR, Glauser TA. Treatment fac-
be used to inform the development of epilepsy-specific
tors affecting longitudinal quality of life in new onset pediatric
intervention protocols and RCT designs to evaluate the effi- epilepsy. J Pediatr Psychol. 2011;36:466–75.
cacy of these interventions in the epilepsy population. Epi- 3. Loiselle K, Ramsey RR, Rausch JR, et al. Trajectories of health-
lepsy health care providers are encouraged to promote related quality of life among youth with newly diagnosed epi-
psychological treatments as an integral part of epilepsy care lepsy. J Pediatr Psychol. 2012;41:1011–21.
and to know the resources available in their area. 4. Ramsey RR, Loiselle K, Rausch JR, et al. Predictors of trajecto-
ries of epilepsy-specific quality of life among children newly
diagnosed with epilepsy. Epilepsy Behav. 2016;57:202–10.
ACKNOWLEDGMENTS 5. Wu YP, Follansbee-Junger K, Rausch J, et al. Parent and family
stress factors predict health-related quality in pediatric patients
We thank the ILAE Commission on Medical Therapies for with new-onset epilepsy. Epilepsia. 2014;55:866–77.
setting up a Psychology Task Force (TF), which led to the 6. Ferro MA, Camfield CS, Levin SD, et al. Trajectories of health-
development of this review. This report was written by the related quality of life in children with epilepsy: a cohort study.
Psychology TF selected by the ILAE and was approved for Epilepsia. 2013;54:1889–97.
MICHAELIS ET AL. | 1299
7. Suurmeijer TP, Reuvenkamp MF, Aldenkamp BP. Social func- 27. Fountain NB, Van Ness PC, Bennett A, et al. Quality improve-
tioning, psychological functioning, and quality of life in epi- ment in neurology: epilepsy update quality measurement set.
lepsy. Epilepsia. 2001;42:1160–8. Neurology. 2015;84:1483–7.
8. Taylor J, Jacoby A, Baker GA, et al. Factors predictive of resilience 28. Gilliam FG, Barry JJ, Hermann BP, et al. Rapid detection of
and vulnerability in new-onset epilepsy. Epilepsia. 2011;52:610–8. major depression in epilepsy: a multicentre study. Lancet Neu-
9. Ridsdale L, Wojewodka G, Robinson E, et al. Characteristics rol. 2006;5:399–405.
associated with quality of life among people with drug-resistant 29. Friedman DE, Kung DH, Laowattana S, et al. Identifying
epilepsy. J Neurol. 2017;264:1174–84. depression in epilepsy in a busy clinical setting is enhanced with
10. Tang V, Michaelis R, Kwan P. Psychobehavioral therapy for systematic screening. Seizure. 2009;18:429–33.
epilepsy. Epilepsy Behav. 2014;32:147–55. 30. Wagner JL, Kellermann T, Mueller M, et al. Development and
11. Wagner JL, Modi AC, Johnson EK, et al. Self-management validation of the NDDI-E-Y: a screening tool for depressive
interventions in pediatric epilepsy: what is the level of evidence? symptoms in pediatric epilepsy. Epilepsia. 2016;57:1265–70.
Epilepsia. 2017;58:743–54. 31. Cramer JA, Perrine K, Devinsky O, et al. Development and
12. Michaelis R, Tang V, Wagner JL, et al. Psychological treatments cross-cultural translations of a 31-item quality of life in epilepsy
for people with epilepsy. Cochrane Database Syst Rev. 2017; inventory. Epilepsia. 1998;39:81–8.
(10):CD012081. 32. Cramer JA, Westbrook LE, Devinsky O, et al. Development of
13. Michaelis R, Tang V, Wagner JL, et al. Cochrane systematic the quality of life in epilepsy inventory for adolescents: the
review and meta-analysis of the impact of psychological treat- QOLIE-AD-48. Epilepsia. 1999;40:1114–21.
ments for people with epilepsy on health-related quality of life. 33. Follansbee-Junger KW, Mann KA, Guilfoyle SM, et al. Devel-
Epilepsia. 2018;59:315–32. opment of the PedsQLTM epilepsy module: focus group and cog-
14. Kerr M, Gil-Nagel A, Glynn M, et al. Treatment of behavioral nitive interviews. Epilepsy Behav. 2016;62:115–20.
problems in intellectually disabled adult patients with epilepsy. 34. Modi AC, Junger KF, Mara C, et al. Validation of the PedsQL
Epilepsia. 2013;54:34–40. epilepsy module: a pediatric epilepsy-specific quality of life
15. Barry JJ, Ettinger AB, Friel P, et al. Consensus statement: the measure. Epilepsia. 2017;58:1920–30.
evaluation and treatment of people with epilepsy and affective 35. Ferro MA, Goodwin SW, Sabaz M, et al. Measurement equiva-
disorders. Epilepsy Behav. 2008;13(suppl 1):S1–29. lence of the newly developed Quality of Life in Childhood Epi-
16. Gross R, Johnston K. Levels of evidence: taking neurology to lepsy Questionnaire (QOLCE-55). Epilepsia. 2016;57:427–35.
the next level. Neurology. 2009;72:8–10. 36. Sabaz M, Lawson JA, Cairns DR, et al. Validation of the quality
17. Atkins D, Best D, Briss PA, et al. Grading quality of evidence of life in childhood epilepsy questionnaire in American epilepsy
and strength of recommendations. BMJ. 2004;28:1490. patients. Epilepsy Behav. 2003;4:680–91.
18. Guyatt GH, Oxman AD, Vist GE, et al. An emerging consensus 37. Marsh L, Rao V. Psychiatric complications in patients with epi-
on rating quality of evidence and strength of recommendations. lepsy: a review. Epilepsy Res. 2002;49:11–33.
BMJ. 2008;336:924–6. 38. Kanner AM, Schachter SC, Barry JJ, et al. Depression and epi-
19. Tolin TF, Forman EM, McKay D. Empirically supported treat- lepsy: epidemiologic and neurobiologic perspectives that may
ment: recommendations for a new model. Clin Psychol Sci explain their high comorbid occurrence. Epilepsy Behav.
Pract. 2015;22:317–38. 2012;24:156–68.
20. Labiner DM, Bagic AI, Herman ST, et al. Essential services, 39. Modi AC, Rausch JR, Glauser TA. Patterns of non-adherence to
personnel, and facilities in specialized epilepsy centers–revised antiepileptic drug therapy in children with newly diagnosed epi-
2010 guidelines. Epilepsia. 2010;51:2322–33. lepsy. JAMA. 2011;305:1669–76.
21. Guilfoyle SM, Follansbee-Junger K, Modi A. Development and 40. Morita DA, Glauser TA, Modi AC. Development and validation
implementation of psychosocial service into standard medical of the Pediatric Epilepsy Side Effects Questionnaire. Neurology.
care for pediatric epilepsy. Clin Pract Pediatr Psychol. 2013;1: 2012;79:1252–8.
276–88. 41. Baker GA, Francis P, Middleton A, et al. Development of a
22. Guilfoyle SM, Monahan S, Wesolowski C, et al. Depression patient-based symptom check list to quantify adverse events in
screening in pediatric epilepsy: evidence for the benefit of a persons receiving antiepileptic drugs. Epilepsia. 1993;34:18.
behavioral medicine service in early detection. Epilepsy Behav. 42. Baker GA, Francis P, Middleton A, et al. Initial development,
2015;44:5–10. reliability, and validity of a patient-based adverse drug event
23. Ryan JL, McGrady ME, Guilfoyle SM, et al. Health care scale. Epilepsia. 1994;35:80.
charges of youth newly diagnosed with epilepsy. Neurology. 43. Mash EJ, Barkley RA. Assessment of childhood disorders. New
2015;85:490–7. York, NY: Guilford Press; 2009.
24. Tellez-Zenteno JF, Patten SB, Jette N, et al. Psychiatric comor- 44. Eiser C, Varni JW. Health-related quality of life and symptom
bidity in epilepsy: a population-based analysis. Epilepsia. 2007; reporting: similarities and differences between children and their
48:2336–44. parents. Eur J Pediatr. 2013;172:1299–304.
25. Selassie AW, Wilson DA, Wagner JL, et al. Population-based 45. CAROLE Group. Epilepsies and time to diagnosis. Descriptive
comparative analysis of risk of death in children and adolescents results of the CAROLE survey. Rev Neurol. 2000;156:481–90.
with epilepsy and migraine. Epilepsia. 2015;56:1957–65. 46. Kwong KL, Wong SN, So KT. Parental perception, worries and
26. Kerr MP, Mensah S, Besag F, et al. International consensus clin- needs in children with epilepsy. Acta Paediatr. 2000;89:593–6.
ical practice statements for the treatment of neuropsychiatric 47. Long L, Reeves AL, Moore JL, et al. An assessment of epilepsy
conditions associated with epilepsy. Epilepsia. 2011;52:2133–8. patients’ knowledge of their disorder. Epilepsia. 2000;41:727–31.
1300
| MICHAELIS ET AL.
48. Sare G, Rawnsley M, Stoneman A, et al. Men with epilepsy— 66. Ridsdale L, Kwan I, Cryer C, et al. Newly diagnosed epilepsy:
the lost tribe? Results of a nationwide survey of men with epi- can nurse specialists help? A randomized controlled trial. Epilep-
lepsy living in the UK. Seizure. 2007;16:384–96. sia. 2000;41:1014–9.
49. Shore C, Austin JK, Musick B, et al. Psychosocial care needs of 67. Yadegary MA, Maemodan FG, Nayeri ND, et al. The effect of
parents of children with new-onset seizures. Neurosci Nurs. self-management training on health-related quality of life in
1998;30:169–74. patients with epilepsy. Epilepsy Behav. 2015;50:108–12.
50. Fraser RT, Johnson EK, Miller JW, et al. Managing epilepsy 68. Quiske A, Helmstaedter C, Lux S, et al. Depression in patients
well: self-management needs assessment. Epilepsy Behav. with temporal lobe epilepsy is related to mesial temporal sclero-
2011;20:291–8. sis. Epilepsy Res. 2000;39:121–5.
51. Shallcross AJ, Becker DA, Singh A, et al. Illness perceptions 69. Mula M. Epilepsy: bidirectional link between epilepsy and psy-
mediate the relationship between depression and quality of life chiatric disorder. Nat Rev Neurol. 2012;8:252–3.
in patients with epilepsy. Epilepsia. 2015;56:186–90. 70. Adelow C, Andersson T, Ahlbom A, et al. Hospitalization for
52. Rawlings G, Brown I, Reuber M. Predictors of health-related psychiatric disorders before and after onset of unprovoked sei-
quality of life in patients with epilepsy and psychogenic zures/epilepsy. Neurology. 2012;78:396–401.
nonepileptic seizures. Epilepsy Behav. 2017;68:153–8. 71. Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and
53. Dash D, Sebastian TM, Aggarwal M, et al. Impact of health suicide attempt as risk factors for incident unprovoked seizures.
education on drug adherence and self-care in people with epi- Ann Neurol. 2006;59:35–41.
lepsy with low education. Epilepsy Behav. 2015;44:213–7. 72. Kanner AM, Byrne R, Chicharro A, et al. A lifetime psychiatric
54. Beretta S, Beghi E, Messina P, et al. Comprehensive educational history predicts a worse seizure outcome following temporal
plan for patients with epilepsy and comorbidity (EDU-COM): a lobectomy. Neurology. 2009;72:793–9.
pragmatic randomised trial. J Neurol Neurosurg Psychiatry. 73. Petrovski S, Szoeke CE, Jones NC, et al. Neuropsychiatric
2014;85:889–94. symptomatology predicts seizure recurrence in newly treated
55. Pf€afflin M, Schmitz B, May TW. Efficacy of the epilepsy nurse: patients. Neurology. 2010;75:1015–21.
results of a randomised controlled study. Epilepsia. 2016;57: 74. Rayner G, Jackson GD, Wilson SJ. Two distinct symptom-based
1190–8. phenotypes of depression in epilepsy yield specific clinical and
56. Helde G, Bovim G, Br athen G, et al. A structured, nurse-led etiological insights. Epilepsy Behav. 2016;64:336–44.
intervention program improves quality of life in patients with 75. Chaytor N, Ciechanowski P, Miller JW, et al. Long-term out-
epilepsy: a randomised, controlled trial. Epilepsy Behav. comes from the PEARLS randomized trial for the treatment of
2005;7:451–7. depression in patients with epilepsy. Epilepsy Behav. 2011;20:
57. Jantzen S, Muller-Godeffroy E, Hallfahrt-Krisl T, et al. FLIP&- 545–9.
FLAP—a training programme for children and adolescents with 76. Ciechanowski P, Chaytor N, Miller J, et al. PEARLS depression
epilepsy, and their parents. Seizure. 2009;18:478–86. treatment for individuals with epilepsy: a randomised controlled
58. May TW, Pfafflin M. The efficacy of an educational treatment trial. Epilepsy Behav. 2010;19:225–31.
program for patients with epilepsy (MOSES): results of a con- 77. Gandy M, Sharpe L, Nicholson Perry K, et al. Cognitive beha-
trolled, randomised study. Epilepsia. 2002;43:39–49. viour therapy to improve mood in people with epilepsy: a ran-
59. Rau J, May TW, Pf€afflin M, et al. Education of children with domised controlled trial. Cogn Behav Ther. 2014;43:153–66.
epilepsy and their parents by the modular education program 78. Orjuela-Rojas JM, Martinez-Juarez IE, Ruiz-Chow A, et al.
epilepsy for families (FAMOSES)—results of an evaluation Treatment of depression in patients with temporal lobe epilepsy:
study [in German]. Rehabilitation (Stuttg). 2006;45:27–39. a pilot study of cognitive behavioral therapy vs. selective sero-
60. Pf€afflin M, Petermann F, Rau J, May TW. The psychoeducational tonin reuptake inhibitors. Epilepsy Behav. 2015;51:176–81.
program for children with epilepsy and their parents (FAMOSES): 79. Schr€ oder J, Br€
uckner K, Fischer A, et al. Efficacy of a psycho-
results of a controlled pilot study and a survey of parent satisfac- logical online intervention for depression in people with epi-
tion over a five-year period. Epilepsy Behav. 2012;25:11–6. lepsy: a randomised controlled trial. Epilepsia. 2014;55:2069–
61. Lua PL, Neni WS. A randomised controlled trial of an SMS- 76.
based mobile epilepsy education system. J Telemed Telecare. 80. Thompson NJ, Walker ER, Obolensky N, et al. Distance deliv-
2013;19:23–8. ery of mindfulness-based cognitive therapy for depression: pro-
62. Pramuka M, Hendrickson R, Zinski A, et al. A psychosocial ject UPLIFT. Epilepsy Behav. 2010;19:247–54.
self-management program for epilepsy: a randomized pilot study 81. Davis GR, Armstrong HE Jr, Donovan DM, et al. Cognitive-
in adults. Epilepsy Behav. 2007;11:533–45. behavioral treatment of depressed affect among epileptics: pre-
63. Aliasgharpour M, Dehgahn Nayeri N, Yadegary MA, et al. liminary findings. J Clin Psychol. 1984;40:930–5.
Effects of an educational program on self-management in 82. Li J, Wang X, Meng H, et al. Systemic family therapy of
patients with epilepsy. Seizure. 2013;22:48–52. comorbidity of anxiety and depression with epilepsy in adoles-
64. Helgeson DC, Mittan R, Tan SY, et al. Sepulveda epilepsy edu- cents. Psychiatry Investig. 2016;13:305–10.
cation: the efficacy of a psychoeducational treatment program in 83. Thompson NJ, Patel AH, Selwa LM, et al. Expanding the effi-
treating medical and psychosocial aspects of epilepsy. Epilepsia. cacy of project UPLIFT: distance delivery of mindfulness-based
1990;31:75–82. depression prevention to people with epilepsy. J Consult Clin
65. Olley BO, Osinowo HO, Brieger WR. Psycho-educational ther- Psychol. 2015;83:304–13.
apy among Nigerian adult patients with epilepsy: a controlled 84. Martinovic Z, Simonovic P, Djokic R. Preventing depression in
outcome study. Patient Educ Couns. 2001;42:25–33. adolescents with epilepsy. Epilepsy Behav. 2006;9:619–24.
MICHAELIS ET AL. | 1301
85. Caller TA, Ferguson RJ, Roth RM, et al. A cognitive behavioral 105. Peterson GM, McLean S, Millingen KS, et al. A randomised
intervention (HOBSCOTCH) improves quality of life and atten- trial of strategies to improve patient compliance with anticonvul-
tion in epilepsy. Epilepsy Behav. 2016;57:111–7. sant therapy. Epilepsia. 1984;25:412–7.
86. Tang V, Poon WS, Kwan P. Mindfulness-based therapy for 106. Dilorio C, Bamps Y, Walker ER, et al. Results of a research
drug-resistant epilepsy: an assessor-blinded randomised trial. study evaluating WebEase, an online epilepsy self-management
Neurology. 2015;85:1100–7. program. Epilepsy Behav. 2011;22:469–74.
87. Tajrishi M, Abbasi S, Najafi Fard T, et al. Efficacy of attribution 107. Dilorio C, Reisinger EL, Yeager KA, et al. A telephone-based
retraining on mental health of epileptic children. Iran Red Cres- self-management program for people with epilepsy. Epilepsy
cent Med J. 2015;17:e19393. Behav. 2009;14:232–6.
88. Tan SY, Bruni J. Cognitive-behavior therapy with adult patients with 108. Modi AC, Mann KA, Urso L, Peugh J. Preliminary feasibility
epilepsy: a controlled outcome study. Epilepsia. 1986;27:225–33. and efficacy of a text and application-based adherence interven-
89. Fraser RT, Johnson EK, Lashley S, et al. PACES in epilepsy: tion in adolescents with epilepsy. Epilepsy Behav. 2016;63:46–9.
results of a self-management randomised controlled trial. Epilep- 109. Lundgren T, Dahl J, Melin L, et al. Evaluation of acceptance
sia. 2015;56:1264–74. and commitment therapy for drug refractory epilepsy: a ran-
90. Dunn DW, Besag F, Caplan R, et al. Psychiatric and beha- domised controlled trial in South Africa—a pilot study. Epilep-
vioural disorders in children with epilepsy (ILAE Task Force sia. 2006;47:2173–9.
Report): anxiety, depression and childhood epilepsy. Epileptic 110. Lundgren T, Dahl J, Yardi N, et al. Acceptance and commit-
Disord. 2016;18:24–30. ment therapy and yoga for drug-refractory epilepsy: a ran-
91. Kellermann T, Mueller M, Carter EG, et al. Prediction of speci- domised controlled trial. Epilepsy Behav. 2008;13:102–8.
fic depressive symptom clusters in youth with epilepsy: NDDI- 111. Reiter JM, Andrews DJ. A neurobehavioral approach for treat-
E-Y vs Neuro-QOL SF. Epilepsia. 2017;58:1370–9. ment of complex partial epilepsy: efficacy. Seizure. 2000;9:198–
92. Ekinci O, Titus JB, Rodopman AA, et al. Depression and anxi- 203.
ety in children and adolescents with epilepsy: prevalence, risk 112. Michaelis R, Schonfeld W, Elsas SM. Trigger self-control and
factors, and treatment. Epilepsy Behav. 2008;14:8–18. seizure arrest in the Andrews/Reiter behavioral approach to epi-
93. Modi AC, Wu YP, Guilfoyle SM, et al. Uninformed clinical lepsy: a retrospective analysis of seizure frequency. Epilepsy
decisions resulting from lack of adherence assessment in chil- Behav. 2012;23:266–71.
dren with new onset epilepsy. Epilepsy Behav. 2012;25:481–4. 113. Au A, Chan F, Li K, et al. Cognitive-behavioral group treatment
94. Modi AC, Pai AL, Hommel KA, et al. Pediatric self-manage- program for adults with epilepsy in Hong Kong. Epilepsy
ment: a framework for research, practice, and policy. Pediatrics. Behav. 2003;4:444–6.
2012;129:473–85. 114. Dahl J, Melin L, Brorson LO, et al. Effects of a broad-spectrum
95. Gollwitzer S, Kostev K, Hagge M, et al. Nonadherence to behavior modification treatment program on children with
antiepileptic drugs in Germany: a retrospective, population-based refractory epileptic seizures. Epilepsia. 1985;26:303–9.
study. Neurology. 2016;87:466–72. 115. Dahl J, Brorson LO, Melin L. Effects of a broad-spectrum
96. Zeber JE, Copeland LA, Pugh MJ, et al. Variation in antiepilep- behavioral medicine treatment program on children with refrac-
tic drug adherence among older patients with new-onset epi- tory epileptic seizures: an 8-year follow-up. Epilepsia.
lepsy. Ann Pharmacother. 2010;44:1896–904. 1992;33:98–102.
97. Shope JT. Compliance in children and adults: review of studies. 116. McLaughlin DP, McFarland K. A randomized trial of a group
Epilepsy Res Suppl. 1988;1:23–47. based cognitive behavior therapy program for older adults with
98. Modi AC, Wu YP, Rausch JR, et al. Antiepileptic drug nonad- epilepsy: the impact on seizure frequency, depression and psy-
herence predicts pediatric epilepsy seizure outcomes. Neurology. chosocial well-being. J Behav Med. 2011;34:201–7.
2014;83:2085–90. 117. Choi-Kwon S, Chung C, Kim H, et al. Factors affecting the
99. Lin CY, Chen H, Pakpour AH. Correlation between adherence quality of life in patients with epilepsy in Seoul, South Korea.
to antiepileptic drugs and quality of life in patients with epi- Acta Neurol Scand. 2003;108:428–34.
lepsy: a longitudinal study. Epilepsy Behav. 2016;63:103–8. 118. Newsom-Davis I, Goldstein LH, Fitzpatrick D. Fear of seizures:
100. Faught RE, Weiner JR, Guerin A, et al. Impact of nonadherence an investigation and treatment. Seizure. 1998;7:101–6.
to antiepileptic drugs on health care utilization and costs: find- 119. Adewuya AO, Ola BA. Prevalence of and risk factors for anxi-
ings from the RANSOM study. Epilepsia. 2009;50:501–9. ety and depressive disorders in Nigerian adolescents with epi-
101. Thomson KE, Modi AC, Glauser TA, et al. The impact of non- lepsy. Epilepsy Behav. 2005;6:342–7.
adherence to antiseizure drugs on seizure outcomes in an animal 120. Jacoby A, Snape D, Baker GA. Epilepsy and social identity: the
model of epilepsy. Epilepsia. 2017;58:1054–62. stigma of a chronic neurological disorder. Lancet Neurol.
102. Faught E, Duh MS, Weiner JR, et al. Nonadherence to 2005;4:171–8.
antiepileptic drugs and increased mortality: findings from the 121. Williams J, Steel C, Sharp GB, et al. Anxiety in children with
RANSOM Study. Neurology. 2008;71:1572–8. epilepsy. Epilepsy Behav. 2003;4:729–32.
103. Pakpour AH, Gholami M, Esmaeili R, et al. A randomised con- 122. Helmstaedter C, Kurthen M, Lux S, et al. Chronic epilepsy and
trolled multimodal behavioral intervention trial for improving cognition: a longitudinal study in temporal lobe epilepsy. Ann
antiepileptic drug adherence. Epilepsy Behav. 2015;52:133–42. Neurol. 2003;54:425–32.
104. Modi AC, Guilfoyle SM, Mann KA, et al. A pilot randomized 123. Tang V, Kwan P, Poon WS. Neurocognitive and psychological
controlled clinical trial to improve antiepileptic drug adherence profiles of adult patients with epilepsy in Hong Kong. Epilepsy
in young children with epilepsy. Epilepsia. 2016;57:e69–75. Behav. 2013;29:337–43.
1302
| MICHAELIS ET AL.
124. Wilson SJ, Baxendale S, Barr W, et al. Indications and expecta- 139. Hosseini N, Mokhtari S, Momeni E, et al. Effect of motivational
tions for neuropsychological assessment in routine epilepsy care: interviewing on quality of life in patients with epilepsy. Epi-
report of the ILAE neuropsychology task force, diagnostic meth- lepsy Behav. 2016;55:70–4.
ods commission, 2013–2017. Epilepsia. 2015;56:674–81. 140. McEwan MJ, Espie CA, Metcalfe J, et al. Quality of life and psy-
125. Samarasekera SR, Helmstaedter C, Reuber M. Cognitive impair- chosocial development in adolescents with epilepsy: a qualitative
ment in adults with epilepsy: the relationship between subjective investigation using focus group methods. Seizure. 2004;13:15–31.
and objective assessments of cognition. Epilepsy Behav. 2015; 141. Ellis N, Upton D, Thompson P. Epilepsy and the family: a
52:9–13. review of current literature. Seizure. 2000;9:22–30.
126. Cohen R, Senecky Y, Shuper A, et al. Prevalence of epilepsy 142. Painter E, Rausch JR, Mod AC. Changes in daily activity pat-
and attention-deficit hyperactivity (ADHD) disorder: a popula- terns of caregivers of children with newly diagnosed epilepsy: a
tion-based study. J Child Neurol. 2013;28:120–3. case-controlled design. Epilepsy Behav. 2014;31:1–6.
127. Guilfoyle SM, Wagner JL, Modi AM, et al. Pediatric epilepsy 143. Mittan RJ. Psychosocial treatment programs in epilepsy: a
and behavioral health: the state of the literature and directions review. Epilepsy Behav. 2009;16:371–80.
for evidence-based interprofessional care, training, and research. 144. Glueckauf RL, Fritz SP, Ecklund-Johnson EP, et al. Videocon-
Clin Pract Pediatr Psychol. 2017;5:79–90. ferencing-based family counseling for rural teenagers with epi-
128. Williams AE, Giust JM, Kronenberger WG, et al. Epilepsy and lepsy: phase 1 findings. Rehabil Psychol. 2002;47:49–72.
attention-deficit hyperactivity disorder: links, risks, and chal- 145. Hufford BJ, Glueckauf RL, Webb PM. Home-based, interactive
lenges. Neuropsychiatr Dis Treat. 2016;12:287–96. videoconferencing for adolescents with epilepsy and their fami-
129. Pelham WE Jr, Fabiano GA, Waxmonsky JG, et al. Treatment lies. Rehabil Psychol. 1999;44:176–93.
sequencing for childhood ADHD: a multiple-randomization 146. Bernard RM, Abrami PC, Lou YP, et al. How does distance
study of adaptive medication and behavioral interventions. J education compare with classroom instruction? A meta-analysis
Clin Child Adolesc Psychol. 2016;2016:396–415. of the empirical literature. Rev Educ Res. 2004;3:379–439.
130. Kerr EN, Blackwell MC. Near-transfer effects following work- 147. Lenhart A. Teen, social media and technology overview. Wash-
ing memory intervention (Cogmed) in children with symp- ington, DC: Pew Research Center; 2015.
tomatic epilepsy: an open randomized clinical trial. Epilepsia. 148. Epilepsy Foundation. UPLIFT [cited 2017 Aug 6]. Available
2015;56:1784–92. from http://www.epilepsy.com/get-help/managing-your-epilepsy/
131. Modi AC, Schmidt M, Smith AW, et al. Development of a Web- self-management-programs/uplift.
based executive functioning intervention for adolescents with epi- 149. MOSES [cited 2017 Aug 6]. Available from http://www.moses-
lepsy: The Epilepsy Journey. Epilepsy Behav. 2017;72:114–21. schulung.de/moses/die-moses-trainer-trainerinnen/.
132. Baker GA, Brooks J, Buck D. The stigma of epilepsy: a Euro- 150. famoses [cited 2017 Aug 6]. Available from http://www.famose
pean perspective. Epilepsia. 2000;41:98–104. s.de/fileadmin/_migrated/content_uploads/FAMOSES-Flyer-Tra
133. Geerts A, Arts WF, Stroink H, et al. Course and outcome of iner-2011_09.pdf.
childhood epilepsy: a 15-year follow-up of the Dutch study of
epilepsy in childhood. Epilepsia. 2010;51:1189–97.
134. Rantanen K, Eriksson K, Nieminen P. Social competence in
children with epilepsy—a review. Epilepsy Behav. 2012;24: How to cite this article: Michaelis R, Tang V,
295–303. Goldstein LH, et al. Psychological treatments for
135. Rodenburg R, Meijer AM, Dekovic M, Aldenkamp AP. Family adults and children with epilepsy: Evidence-based
factors and psychopathology in children with epilepsy: a litera- recommendations by the International League
ture review. Epilepsy Behav. 2005;6:488–503. Against Epilepsy Psychology Task Force. Epilepsia.
136. Goffman E. Stigma: notes on the management of spoiled iden- 2018;59:1282–1302. https://doi.org/10.1111/
tity. Englewood Cliffs, NJ: Prentice Hall; 1963.
epi.14444
137. Santosh D, Kumar TS, Sarma PS, et al. Women with onset of
epilepsy prior to marriage: disclose or conceal? Epilepsia.
2007;48:1007–10.
138. Lau KK, Ng PW, Chan CW, et al. Announcement of a new
Chinese name for epilepsy. Epilepsia. 2011;52:420–1.